Kovitz Investment Group Partners LLC Has $19.78 Million Position in CVS Health Corporation $CVS

Kovitz Investment Group Partners LLC raised its holdings in shares of CVS Health Corporation (NYSE:CVS) by 27.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 262,363 shares of the pharmacy operator’s stock after acquiring an additional 56,476 shares during the period. Kovitz Investment Group Partners LLC’s holdings in CVS Health were worth $19,780,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Alteri Wealth LLC lifted its stake in CVS Health by 3.2% in the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after buying an additional 131 shares during the period. Vestmark Advisory Solutions Inc. raised its position in shares of CVS Health by 154.1% in the 3rd quarter. Vestmark Advisory Solutions Inc. now owns 16,185 shares of the pharmacy operator’s stock valued at $1,220,000 after acquiring an additional 9,815 shares during the period. Michels Family Financial LLC boosted its stake in CVS Health by 1.8% during the 3rd quarter. Michels Family Financial LLC now owns 10,420 shares of the pharmacy operator’s stock worth $786,000 after acquiring an additional 187 shares during the last quarter. Bleakley Financial Group LLC increased its stake in CVS Health by 140.9% in the third quarter. Bleakley Financial Group LLC now owns 64,486 shares of the pharmacy operator’s stock valued at $4,862,000 after purchasing an additional 37,721 shares in the last quarter. Finally, Lansforsakringar Fondforvaltning AB publ boosted its position in shares of CVS Health by 2.3% during the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 398,612 shares of the pharmacy operator’s stock worth $30,051,000 after purchasing an additional 8,992 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the topic of several research analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. The Goldman Sachs Group raised their price target on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Wells Fargo & Company lowered their target price on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research note on Thursday, November 13th. Wall Street Zen cut shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Finally, Barclays raised their price objective on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Trading Down 0.9%

Shares of NYSE:CVS opened at $76.64 on Monday. The company’s 50-day moving average price is $78.52 and its two-hundred day moving average price is $76.87. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The stock has a market capitalization of $97.50 billion, a PE ratio of 55.53, a price-to-earnings-growth ratio of 0.80 and a beta of 0.50.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter last year, the company earned $1.19 EPS. CVS Health’s revenue for the quarter was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.